Company Analysis

Agenus Inc. (AGEN)

Nasdaq: AGEN · Biological Products, (No Diagnostic Substances) · Lexington, MA · filing with the SEC since 1999
Grade4.5
◀ Past 3.5● Present 5.2▶ Future 4.5
1 est.

Filings

326 filings since 2017 beside 447 insider forms · Accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026
Due nextAccelerated filer and smaller reporting company
10-K Annual report for the fiscal year ending Dec 31, 2026Accelerated filers have 75 days after the fiscal year ends. by Mar 16, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end. by May 10, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 36 days after the quarter ended. The proxy statement was last filed Apr 30, 2026.

Filings a yearinsider forms included
7986745860998076
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 8 times in the last 36 months, the newest Aug 13, 2026.Listing warning from its exchange (8-K item 3.01): 1 time in the last 36 months, the newest Dec 8, 2023.SEC letters: 2 in the last 36 months, the newest May 28, 2025.
Insider forms 447

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 5, 2026 10-Q Quarterly report Sep 30, 2026
Nov 5, 2026 8-K items 2.02, 9.01 Results released · Current report
Sep 11, 2026 S-3 Shelf registration
Sep 2, 2026 S-8 Employee stock plan registration
Aug 18, 2026 8-K items 1.01, 2.03, 3.02 Major agreement signed; New debt or obligation taken on; Shares sold without registration · Current report Aug 12, 2026
Aug 17, 2026 424B3 Shelf offering
Aug 14, 2026 EFFECT Registration effective
Aug 13, 2026 8-K item 5.02 Officer or director change · Current report Aug 10, 2026
Aug 11, 2026 8-K item 5.02 Officer or director change · Current report Aug 5, 2026
Aug 7, 2026 10-Q Quarterly report Jun 30, 2026
Aug 7, 2026 S-8 Employee stock plan registration
Aug 7, 2026 S-3 Shelf registration
Aug 6, 2026 8-K item 2.02 Results released · Current report
Jul 27, 2026 EFFECT Registration effective
Jul 27, 2026 SCHEDULE 13G Large holder notice
Jul 20, 2026 SCHEDULE 13G Large holder notice
Jul 20, 2026 S-3 Shelf registration
Jul 17, 2026 SCHEDULE 13G Large holder notice
Jul 13, 2026 8-K items 1.01, 3.02, 7.01, 8.01, 9.01 Major agreement signed; Shares sold without registration; Investor disclosure (Regulation FD); Other event · Current report
Jul 6, 2026 8-K item 1.01 Major agreement signed · Current report Jun 29, 2026
Jun 23, 2026 8-K item 5.07 Shareholder vote · Current report Jun 16, 2026
May 15, 2026 8-K item 5.02 Officer or director change · Current report May 12, 2026
May 13, 2026 DEFA14A Extra proxy material
May 11, 2026 10-Q Quarterly report Mar 31, 2026
May 11, 2026 8-K items 2.02, 9.01 Results released · Current report
Apr 30, 2026 ARS Annual report to shareholders Dec 31, 2025
Apr 30, 2026 DEF 14A Proxy statement
Apr 20, 2026 PRE 14A Preliminary proxy statement
Mar 26, 2026 8-K item 8.01 Other event · Current report Mar 24, 2026
Mar 26, 2026 SCHEDULE 13G/A Large holder update, amended
Mar 16, 2026 10-K Annual report Dec 31, 2025
Mar 16, 2026 8-K items 2.02, 9.01 Results released · Current report
Jan 23, 2026 SCHEDULE 13D Activist holder notice
Jan 16, 2026 8-K items 2.01, 3.02, 7.01, 9.01 Purchase or sale of a business completed; Shares sold without registration; Investor disclosure (Regulation FD) · Current report Jan 15, 2026
Jan 14, 2026 8-K item 5.02 Officer or director change · Current report Jan 8, 2026
Jan 8, 2026 8-K items 1.01, 3.03 Major agreement signed; Change to shareholders' rights · Current report Jan 3, 2026
Dec 29, 2025 S-3ASR Shelf registration
Nov 10, 2025 10-Q Quarterly report Sep 30, 2025
Nov 10, 2025 8-K items 2.02, 9.01 Results released · Current report
Oct 30, 2025 SCHEDULE 13G/A Large holder update, amended
40 of 326 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton AGEN · research, not advice